| Style | Citing Format |
|---|---|
| MLA | Salari M, et al.. "Seroprevalence of Sars-Cov-2 in Parkinson's Disease Patients: A Case–Control Study." Movement Disorders, vol. 36, no. 4, 2021, pp. 794-795. |
| APA | Salari M, Etemadifar M, Zali A, Medghalchi A, Tehrani Fateh S, Aminzade Z, Bagheri Moghaddam S (2021). Seroprevalence of Sars-Cov-2 in Parkinson's Disease Patients: A Case–Control Study. Movement Disorders, 36(4), 794-795. |
| Chicago | Salari M, Etemadifar M, Zali A, Medghalchi A, Tehrani Fateh S, Aminzade Z, Bagheri Moghaddam S. "Seroprevalence of Sars-Cov-2 in Parkinson's Disease Patients: A Case–Control Study." Movement Disorders 36, no. 4 (2021): 794-795. |
| Harvard | Salari M et al. (2021) 'Seroprevalence of Sars-Cov-2 in Parkinson's Disease Patients: A Case–Control Study', Movement Disorders, 36(4), pp. 794-795. |
| Vancouver | Salari M, Etemadifar M, Zali A, Medghalchi A, Tehrani Fateh S, Aminzade Z, et al.. Seroprevalence of Sars-Cov-2 in Parkinson's Disease Patients: A Case–Control Study. Movement Disorders. 2021;36(4):794-795. |
| BibTex | @article{ author = {Salari M and Etemadifar M and Zali A and Medghalchi A and Tehrani Fateh S and Aminzade Z and Bagheri Moghaddam S}, title = {Seroprevalence of Sars-Cov-2 in Parkinson's Disease Patients: A Case–Control Study}, journal = {Movement Disorders}, volume = {36}, number = {4}, pages = {794-795}, year = {2021} } |
| RIS | TY - JOUR AU - Salari M AU - Etemadifar M AU - Zali A AU - Medghalchi A AU - Tehrani Fateh S AU - Aminzade Z AU - Bagheri Moghaddam S TI - Seroprevalence of Sars-Cov-2 in Parkinson's Disease Patients: A Case–Control Study JO - Movement Disorders VL - 36 IS - 4 SP - 794 EP - 795 PY - 2021 ER - |